Current application and future directions for the sarcopenic obesity Global Leadership Initiative (SOGLI) diagnostic algorithm - PubMed
3 hours ago
- #Sarcopenic Obesity
- #Diagnostic Algorithm
- #Clinical Review
- Sarcopenic obesity (SO) is defined by excess fat and reduced muscle mass/function.
- The Sarcopenic Obesity Global Leadership Initiative (SOGLI) introduced a diagnostic algorithm in 2022 to standardize SO identification, including screening, assessment, and staging.
- A review of 72 studies from 2022-2025 evaluated the algorithm's application, noting varied approaches in clinical settings.
- For obesity screening, half used BMI and waist circumference; sarcopenia screening was less common.
- Bioelectrical impedance analysis was the primary method for body composition assessment in SO diagnosis.
- Hand-grip strength was the most used measure for evaluating muscle function.
- SO staging was reported in 19% of studies, mostly as Stage II.
- The algorithm confirmed links between SO and chronic diseases, functional decline, and higher mortality.
- While the SOGLI algorithm is a significant advance, inconsistencies in screening and staging suggest areas for improvement.
- Future refinements could include better standardization and integration of new biomarkers to boost clinical effectiveness.